First Page | Document Content | |
---|---|---|
Date: 2013-06-27 13:50:54 | NOVEN TO ACQUIRE DAYTRANA® METHYLPHENIDATE TRANSDERMAL SYSTEM FROM SHIRE The First and Only Patch for ADHD to be Marketed and Sold by Noven Therapeutics Miami, FL, August 10, Noven Pharmaceuticals, Inc. today anAdd to Reading ListSource URL: www.noven.comDownload Document from Source WebsiteFile Size: 143,59 KBShare Document on Facebook |